about
Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's DiseaseOptimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's diseaseEffects of dopamine on sensitivity to social bias in Parkinson's diseasePhenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson's disease, atypical Parkinsonian disorders and non-Parkinsonian populations.Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease?Novelty seeking behaviour in Parkinson's disease.Exenatide and the treatment of patients with Parkinson's diseaseDopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease.Altruistic punishment in patients with Parkinson's disease with and without impulsive behaviour.Stroop test performance in impulsive and non impulsive patients with Parkinson's diseaseIn a rush to decide: deep brain stimulation and dopamine agonist therapy in Parkinson's disease.Risk and learning in impulsive and nonimpulsive patients with Parkinson's diseaseSalivary cortisol levels in Parkinson's disease and its correlation to risk behaviour.Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?Haste makes waste: Decision making in patients with restless legs syndrome with and without augmentation.Jumping to conclusions in untreated patients with Parkinson's disease.Uncertainty about mapping future actions into rewards may underlie performance on multiple measures of impulsivity in behavioral addiction: evidence from Parkinson's disease.Increased reflection impulsivity in patients with ephedrone-induced Parkinsonism.Pathological gambling in Parkinson's disease--a review of the literature.Clinical aspects of impulsive compulsive behaviours in Parkinson's disease.Can stress trigger Parkinson's disease?Neurobehavioral Sequelae of Psychostimulant Abuse.Probable RBD and association with neurodegenerative disease markers: A population-based study.Nonmotor symptoms in subjects without evidence of dopaminergic deficits.Concomitant fragile X-associated tremor ataxia syndrome and Parkinson's disease: a clinicopathological report of two cases.Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease.Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy.Anxiety and depression in Parkinson's disease.A novel mutation in the VCP gene (G157R) in a German family with inclusion-body myopathy with Paget disease of bone and frontotemporal dementia.MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.Compulsive sexual behaviour in Parkinson's disease is associated with higher doses of levodopa.The reorganization of functional architecture in the early-stages of Parkinson's disease.Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.Perceptual decision-making in patients with Parkinson's disease.Impaired information sampling in mild dementia of Alzheimer's type but not in healthy aging.Excessive hoarding in Parkinson's disease.Improvements in rate of development and magnitude of force with intense auditory stimuli in patients with Parkinson's disease.Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours.Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.Cannabinoids for Treatment of Dystonia in Huntington's Disease.
P50
Q26776152-A69C160A-2FF9-4E83-90ED-4636ABA7CCB5Q28071861-9261E96A-FEE9-4352-8114-360DBC8C795FQ28731410-60B17C56-A191-4D29-9937-550357AE02AEQ30238907-BCFC1D9C-FD11-4414-8CF4-117CFE63EE8CQ30454441-2B51E46F-BFC0-4DAB-9AE1-A92B89BA0B1DQ30466231-3AC29E98-B186-4647-A776-FCDC8A15D855Q30540208-ED3F3DC2-3E70-4124-A4EB-29AC53BF5741Q34385659-CC38ECD8-9770-4681-B972-9B4B0059C258Q34420120-7708DE41-4454-415B-BEF0-4773FFE10D52Q34587645-12FDBC2D-43DA-48D3-BFD3-1A823BD30771Q34633300-EB9D4114-CC56-4B91-BB68-A374BAEE9E63Q34976392-DA2D7693-94C9-41C6-ABBD-BF87AEADD7D8Q35210320-8B0C7D49-A171-4344-8C4F-DCADCF65311FQ36143856-F8093C78-1F95-4F5B-A7CE-5AE9AF9D46FEQ36336099-F6E331BA-C6C7-4D09-B3C5-885273447ECDQ37401362-751C57FF-2074-49EA-9A53-B8EFED552E67Q37604101-FE0BB15C-2752-4B64-9721-3FB8D8184445Q37609711-8180C9E8-A5A1-4415-846D-8030046067D6Q37887679-CEB390C5-476B-4409-895F-064C90BE9C8DQ37916884-FDD28033-45E9-47EF-9203-F06B6EAB043BQ38164648-F677D4F5-CEC3-4313-B53B-C9718F78A255Q38526706-3D2607B5-7E43-4E0F-A329-27926D3E250FQ38981556-6054A367-2FFF-4C05-8475-507E39569F58Q41219724-B111F9E1-7F18-4D63-B7B4-485B6414E32EQ42393280-35524751-1001-4BCA-AD83-6792C92E216DQ42650570-79BACD2C-2929-447F-BCC2-C5B36269F01AQ43137475-191E6FF7-6F98-4EBB-A0BB-590C1326F421Q43491031-326C4B32-7B45-4100-90E6-1CD20C51CF1CQ46126082-5AFF87E6-388E-4657-8504-9B71A893455CQ47612445-538C0CBC-3390-453A-BCE2-2CFDC2564188Q49629461-6F762978-27FD-4602-9B9C-5A4A5737C0F6Q49961768-972460F4-E8C4-4BC7-AEB9-2A41679C7D1AQ50045027-310EAB06-A603-439C-9BD9-B9C09159628FQ50222006-9A5C375C-444A-4E02-B7E6-328799546C2AQ50625536-5FA418CB-A7DB-4197-A38E-486DE900476CQ50708516-0369924A-5089-4447-927A-2C7DE86FF569Q51865061-1FCD3392-76B0-402D-837C-609216553F7CQ51887913-1F4AEFEB-00B6-4429-ADF1-08EB49103C9DQ52709162-F723E4A2-5C84-46A5-8438-FD7D3A4AC968Q53429245-7303642D-1E07-4BB0-B2DD-90964FA01B88
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Atbin Djamshidian
@ast
Atbin Djamshidian
@en
Atbin Djamshidian
@es
Atbin Djamshidian
@nl
type
label
Atbin Djamshidian
@ast
Atbin Djamshidian
@en
Atbin Djamshidian
@es
Atbin Djamshidian
@nl
prefLabel
Atbin Djamshidian
@ast
Atbin Djamshidian
@en
Atbin Djamshidian
@es
Atbin Djamshidian
@nl
P106
P31
P496
0000-0001-7174-6000